What is Cherokee Rose Root used for?

Cherokee Rose Root (Rosa laevigata) is used in Traditional Chinese Medicine as an adaptogen to address inflammation, oxidative stress, and overall resilience. Preclinical evidence shows it reduces auricular swelling by 9.86% and lowers biomarkers of oxidative damage including ROS and MDA through Nrf2/HO-1 pathway activation. Human clinical evidence remains limited, so current use is primarily rooted in traditional practice and animal-model research.

What are the active compounds in Rosa laevigata?

The primary bioactive constituents of Rosa laevigata root include polyphenols, flavonoids, tannins, and triterpenoids. Flavonoids and polyphenols are responsible for the observed Nrf2/HO-1 antioxidant signaling activation, while triterpenoids contribute to its anti-inflammatory effects by inhibiting pro-inflammatory mediators. These compound classes collectively account for the majority of the pharmacological activity documented in preclinical studies.

Is Cherokee Rose Root safe to take as a supplement?

Cherokee Rose Root has a long history of use in Traditional Chinese Medicine with no widely documented severe adverse events at conventional decoction doses. However, individuals with Rosaceae family allergies should exercise caution, and those taking anticoagulants like warfarin should consult a healthcare provider due to potential flavonoid-mediated interactions with clotting pathways. No standardized safe dosage for supplements has been established through human clinical trials, making professional guidance advisable before use.

How does Cherokee Rose Root reduce inflammation?

Cherokee Rose Root reduces inflammation primarily through its triterpenoid and flavonoid constituents, which suppress the production and activity of pro-inflammatory mediators in affected tissues. In mouse models, oral or topical application produced a 9.86% reduction in auricular swelling and a 22.39% reduction in granulation tissue, which are standard markers of acute and chronic inflammation respectively. Simultaneously, upregulation of HO-1 via the Nrf2 pathway reduces oxidative stress, a key driver of inflammatory cascades.

Does Cherokee Rose Root have human clinical trial evidence?

As of current published literature, Cherokee Rose Root lacks large-scale randomized controlled human clinical trials to validate the benefits observed in preclinical animal models. Existing quantified data — including the 22.39% granulation tissue reduction and Nrf2/HO-1 antioxidant outcomes — come exclusively from mouse model studies. Until well-designed human trials are conducted, health claims for this ingredient should be interpreted with appropriate caution regarding direct applicability to human physiology.

What does the research show about Cherokee Rose Root's antioxidant effects?

Preclinical studies demonstrate that Cherokee Rose Root reduces oxidative stress by decreasing reactive oxygen species (ROS) and malondialdehyde (MDA) levels through activation of the Nrf2 and HO-1 antioxidant pathways. These findings are based on laboratory and animal model research only, and human clinical evidence is currently lacking. The antioxidant mechanism suggests potential benefits for cells under oxidative stress, though more research is needed to confirm efficacy in humans.

Does Cherokee Rose Root have protective effects on kidney health?

Research in animal models suggests Cherokee Rose Root may support renal health by reducing key inflammatory markers including NF-κB p65, MCP-1, and Keap1 expression. These renoprotective effects indicate potential benefits for kidney function through anti-inflammatory pathways. However, these findings are limited to preclinical studies, and human evidence is needed to establish clinical relevance and recommended use for kidney support.

How much inflammatory reduction does Cherokee Rose Root show in research studies?

In mouse models, Cherokee Rose Root demonstrated a 9.86% reduction in auricular (ear) swelling and a notable 22.39% reduction in granulation tissue formation. These quantified anti-inflammatory effects were observed in preclinical research settings and provide a baseline for understanding the ingredient's potential mechanisms. These results are promising but cannot be directly extrapolated to human supplementation without clinical trial data.

Cherokee Rose Root (Rosa laevigata)

Cherokee Rose Root (Rosa laevigata) is a Traditional Chinese Medicine adaptogen whose primary bioactive compounds include polyphenols, flavonoids, and triterpenoids that modulate oxidative stress pathways. It exerts anti-inflammatory and antioxidant effects primarily by upregulating the Nrf2/HO-1 signaling axis and suppressing reactive oxygen species and malondialdehyde production.

Category: Adaptogen Evidence: 2/10 Tier: Emerging

Cherokee Rose Root (Rosa laevigata) — Hermetica Encyclopedia

Origin & History

Cherokee Rose Root (Radix Rosa laevigata) is the dried root of Rosa laevigata Michx., a climbing rose species native to East Asia, particularly China. The root is typically processed through aqueous decoctions or extraction of total flavonoids (TFs) from the dried root material. It belongs to the Rosaceae family and contains polyphenolic flavonoids and triterpenoids as its primary bioactive compounds.

Historical & Cultural Context

In traditional Chinese medicine (TCM), Rosa laevigata root (Radix Rosa Laevigatae) has been used for centuries to treat inflammatory conditions, urinary disorders, and as an astringent. Historical applications include anti-inflammatory, antiviral, anti-tumor, immunomodulatory, lipid-lowering, and cardiovascular effects, which modern pharmacology has begun to investigate through preclinical studies.

Health Benefits

• Anti-inflammatory effects: Preclinical studies show 9.86% reduction in auricular swelling and 22.39% reduction in granulation tissue in mouse models
• Antioxidant protection: Decreases reactive oxygen species (ROS) and malondialdehyde (MDA) levels through Nrf2 and HO-1 upregulation (preclinical evidence only)
• Renoprotective effects: Lowers inflammatory markers NF-κB p65, MCP-1, and Keap1 while boosting antioxidant enzyme GSH-Px (animal studies)
• Cardiovascular support: Traditional use supported by modern pharmacology showing lipid-lowering effects (preclinical data)
• Immune modulation: Demonstrates immunomodulatory effects through cytokine regulation including IL-1, IL-6, and TNF-α suppression (in vitro/animal models)

How It Works

Cherokee Rose Root's bioactive polyphenols and flavonoids activate the Nrf2 transcription factor, which translocates to the nucleus and upregulates heme oxygenase-1 (HO-1), reducing intracellular reactive oxygen species (ROS) and lipid peroxidation marker malondialdehyde (MDA). Its triterpenoid constituents inhibit pro-inflammatory mediators, contributing to measured reductions in granulation tissue formation and edema in preclinical auricular swelling models. These combined pathways position Rosa laevigata as an adaptogen capable of modulating both oxidative and inflammatory stress responses at the cellular level.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Cherokee Rose Root were identified in the research. Available evidence is limited to preclinical pharmacological studies in cell cultures and animal models. Related rose species studies include a pilot RCT (n=40, PMID: 34466491) on Rosa damascena oil for ulcerative colitis showing non-significant trends, and a review of 13 trials (n=772, PMID: 28748167) on rose oil for various conditions.

Clinical Summary

Available evidence for Cherokee Rose Root is currently limited to preclinical animal models, with no large-scale randomized controlled human trials published to date. Mouse model studies demonstrated a 9.86% reduction in auricular swelling and a 22.39% reduction in granulation tissue weight, indicating meaningful but modest anti-inflammatory activity in vivo. Antioxidant endpoints including decreased ROS and MDA levels have been confirmed in these same preclinical settings through Nrf2 and HO-1 pathway analysis. The overall evidence base must be considered preliminary, and extrapolation of these findings to human clinical outcomes requires rigorous controlled trials.

Nutritional Profile

Cherokee Rose Root (Rosa laevigata) contains a complex array of bioactive compounds rather than significant macronutrient content, as it is used medicinally in small doses rather than as a food source. Key bioactive constituents include: Triterpenoids and pentacyclic triterpenes (including ursolic acid and oleanolic acid, estimated 0.5–2% dry weight), which are primary contributors to anti-inflammatory activity. Polyphenolic compounds are prominent, including tannins (ellagitannins and gallotannins, approximately 8–15% dry weight), flavonoids such as quercetin, kaempferol, and rutin (combined estimated 1–3% dry weight), and phenolic acids including gallic acid and ellagic acid. Saponins have been identified (estimated 1–2% dry weight), contributing to adaptogenic and renoprotective properties. Polysaccharides are present in the root (estimated 10–20% dry weight) and have demonstrated immunomodulatory effects in preclinical models. Carotenoids are present in trace amounts. Minerals detected include potassium, calcium, magnesium, and iron, though concentrations in the root are modest and not well-quantified in available literature. Fiber content is moderate given the woody root structure (estimated 15–25% dry weight as structural cellulose and lignin). Bioavailability notes: Ellagitannins are converted by gut microbiota to urolithins, which are the primary bioavailable metabolites responsible for antioxidant and anti-inflammatory effects; this conversion is microbiome-dependent and varies significantly between individuals. Fat-soluble triterpenes have limited oral bioavailability without lipid carriers. Most quantitative data derives from Chinese Pharmacopoeia analyses and preclinical studies; human pharmacokinetic data remains limited.

Preparation & Dosage

No clinically studied human dosages available. Preclinical data: aqueous root extracts at 0.2 ml/10 g body weight in mice; related fruit extracts used 5 g/kg/day aqueous in rats or 50-200 mg/kg total flavonoids. In vitro studies used 100-300 μg/ml total flavonoids or 125-250 μg/ml aqueous extracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green Tea Extract, Turmeric, Quercetin, Resveratrol, Ginger Root

Safety & Interactions

No standardized human safety profile or established tolerable upper intake level exists for Cherokee Rose Root due to the absence of robust clinical trial data. Traditional use in Chinese herbal medicine suggests general tolerability at customary decoction doses, but allergic reactions are possible given its membership in the Rosaceae family, particularly in individuals sensitive to rose-family plants. Potential interactions with anticoagulant drugs such as warfarin are a theoretical concern given the flavonoid and tannin content, which can influence platelet aggregation and cytochrome P450 enzyme activity. Pregnant or breastfeeding individuals should avoid use until safety data from controlled human studies are available.